Bio-Rad Laboratories, Inc. Class A Common Stock vs Bank of Montreal — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B), while Bank of Montreal trades at $180.98 (market cap $124.81B). The key difference: Bank of Montreal is far larger — about 15.6× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Bank of Montreal pays a 2.77% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | BMO | |
|---|---|---|
Market Cap | $8.02B | $124.81B |
Sector | Health | Financials |
52-Week High | $339.75 | $180.86 |
52-Week Low | $241.71 | $110.44 |
Enterprise Value | $7.84B | — |
Dividend Yield | — | 2.77% |
Trailing returns across standard periods
Latest headlines on both assets
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →